Pimasertib-associated ophthalmological adverse events

Dijk, E.H.C. van; Kruit, W.H.J.; Jager, M.J.; Luyten, G.P.M.; Vingerling, J.R.; Boon, C.J.F. (2018)

Article / Letter to editor

• mitogen-activated protein kinase kinase inhibitor
• ophthalmological adverse events
• pimasertib
• retinal vein occlusion
• serous retinopathy

• All authors: Dijk, E.H.C. van; Kruit, W.H.J.; Jager, M.J.; Luyten, G.P.M.; Vingerling, J.R.; Boon, C.J.F.
• Date: 2018-11-30
• Journal: Acta Ophthalmologica
• Volume: 96
• Issue: 7
• Pages: 712 - 718
• DOI: doi:10.1111/aos.13677